MASHINIi

Psyence Biomedical Ltd..

PBM.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products

Psyence Biomedical Ltd. is a biotechnology company focused on the development and commercialization of psychedelic medicines. The company cultivates, extracts, and manufactures psilocybin, the active ingredient in magic mushrooms, for use in clinical trials and ultimately, pharmaceutical products. T...Show More

Ethical Profile

Mixed.

Psyence Biomedical Ltd. focuses on developing nature-derived psilocybin-based therapeutics for mental health, specifically Adjustment Disorder in palliative care, which affects 2.25 million US/EU cancer patients annually. Their lead product, PEX010, is in a Phase IIb clinical trial with 87 patients, with full approval from the Australian Health Research Ethics Committee. Top-line results are expected in Q1 2025. The company is ISO22000 certified. While Psyence Biomedical has an insider trading policy and a whistleblower hotline, reports suggest limited public data on fair pay, worker respect, or environmental practices. Critics also point to the potential for ethical sourcing challenges given its reliance on naturally derived psilocybin, which could impact local communities and ecosystems, though specific details on their supply chain practices are not publicly available.

Value Scores

Better Health for All30
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business-40
-100100
Kind to Animals0
-100100
No War, No Weapons0
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

30

Psyence Biomedical Ltd. has received full approval from the Australian Health Research Ethics Committee (HREC) for its Phase IIb clinical trial.

1
The trial is designed as a randomized, double-blind, placebo-controlled study, which are standard ethical practices in clinical trials.
2
PsyLabs, a subsidiary, is ISO22000 certified and audited by the British Standards Institution.
3

Fair Money & Economic Opportunity

0

No evidence available to assess Psyence Biomedical Ltd. on Fair Money & Economic Opportunity.

Fair Pay & Worker Respect

0

The provided articles do not contain sufficient specific, quantitative data to assess Psyence Biomedical Ltd. against any of the KPIs for Fair Pay & Worker Respect. Information regarding living wage coverage, CEO to median employee pay ratio, collective bargaining share, safety incident rates, pay equity ratio, worker engagement scores, turnover rate, labor violation incidents, insecure contract share, or health insurance coverage is explicitly stated as not provided, not applicable, or not in a usable format for calculation across the available documents.

1

Fair Trade & Ethical Sourcing

0

No evidence available to assess Psyence Biomedical Ltd. on Fair Trade & Ethical Sourcing.

Honest & Fair Business

-40

The company provides a whistleblower hotline, which is managed by a third-party administrator.

1
Complaints received through this hotline are directed to the Audit Committee.
2
No other specific, concrete data points were found for the remaining KPIs.

Kind to Animals

0

No evidence available to assess Psyence Biomedical Ltd. on Kind to Animals.

No War, No Weapons

0

Psyence Biomedical Ltd. is a biotechnology company focused on developing and commercializing psychedelic medicines for mental health conditions. Its core business activities, including cultivation, extraction, and manufacturing of psilocybin, are unrelated to arms, defense, or military operations. Therefore, all KPIs related to military involvement, dual-use technology, arms trade, defense contracts, or conflict-zone operations are not applicable to the company's core business model.

Planet-Friendly Business

0

No data relevant to Planet-Friendly Business metrics, environmental performance, or sustainability initiatives for Psyence Biomedical Ltd. (PBM.US) was found in the provided articles. The articles primarily focus on financial reports, investor presentations, conference participation, board appointments, and debt settlement. Information regarding environmental, social, or governance (ESG) factors, including specific quantitative data for any of the defined KPIs, is not present. The ISO22000 certification for PsyLabs is a food safety standard and not relevant to environmental KPIs.

1

Respect for Cultures & Communities

0

The provided articles discuss Psyence BioMed's Chief of Global Impact speaking at a conference

1
and private placement financing for Psyence Group Inc.
2
They do not contain any specific, concrete data points regarding PBM.US's community engagement, cultural sensitivity practices, or any other metrics relevant to the 'Respect for Cultures & Communities' value.

Safe & Smart Tech

0

The company's privacy policy outlines user rights to access, correct, and delete data.

1
The policy also states that the company collects only necessary data and addresses compliance with regulations such as GDPR and CCPA.
2
No further details on implementation or effectiveness are provided.

Zero Waste & Sustainable Products

0

No evidence available to assess Psyence Biomedical Ltd. on Zero Waste & Sustainable Products.

Own Psyence Biomedical Ltd.?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.